Recent News for MRVI - Maravai LifeSciences Holdings, Inc.

Date Title
Apr 8 Maravai LifeSciences prices upsized secondary offering at $31.25
Apr 8 Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
Apr 6 Maravai’s 1Q Revenue Outlook Misses Estimates; Street Sees Over 34% Upside
Apr 6 Maravai LifeSciences expects Q1 revenue above consensus, prior guidance
Apr 6 Maravai LifeSciences launches secondary offering
Apr 5 Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
Apr 5 Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
Mar 15 Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
Mar 8 Maravai Lifesciences Holdings (MRVI) Investor Presentation - Slideshow
Mar 7 Analysts Just Made A Dazzling Upgrade To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Forecasts
Mar 3 Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Q4 2020 Earnings Call Transcript
Mar 3 Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q4 2020 Results - Earnings Call Transcript
Mar 3 Dow Jones Futures: Stock Market Rally Falls To Key Support As Nio, Zoom, Target Dive; Vaccine Play Soars Late
Mar 2 Maravai LifeSciences Holdings EPS beats by $0.04, beats on revenue
Mar 2 Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
Mar 2 Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A to Host Earnings Call
Mar 2 Earnings Scheduled For March 2, 2021
Mar 1 10 Best New Stocks To Buy Now
Mar 1 Maravai LifeSciences Announces March 2021 Investor Conference Schedule
Feb 22 Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) About To Shift From Loss To Profit
Feb 10 Maravai LifeSciences Expands Its Intellectual Property Portfolio
Feb 1 88 Biggest Movers From Friday
Jan 28 Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
Jan 26 Breakout Watch: IPO Leader, Pfizer Vaccine Partner MRVI Stock Enters Buy Zone
Jan 21 The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Back to the Main MRVI Page...